Plasma exosomal prion protein levels are correlated with cognitive decline in PD patients
- 25 February 2020
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 723, 134866
- https://doi.org/10.1016/j.neulet.2020.134866
Abstract
No abstract availableKeywords
Funding Information
- Natural Fund Guidance Program of Liaoning Province (20180551152)
This publication has 26 references indexed in Scilit:
- Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)Zeitschrift für Neurologie, 2018
- Physiological and pathological roles of exosomes in the nervous systemBioMolecular Concepts, 2016
- Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's diseaseParkinsonism & Related Disorders, 2015
- Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular VesiclesAnnual Review of Cell and Developmental Biology, 2014
- New light on prions: putative role of co-operation of PrPc and Aβ proteins in cognitionFolia Neuropathologica, 2014
- Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatmentThe Lancet Neurology, 2012
- Total Prion Protein Levels in the Cerebrospinal Fluid are Reduced in Patients with Various Neurological DisordersJournal of Alzheimer's Disease, 2009
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 yearsMovement Disorders, 2008
- Physiology of the Prion ProteinPhysiological Reviews, 2008
- Risk of dementia in Parkinson’s diseaseNeurology, 2001